InvestorsHub Logo
icon url

hope4patients

05/12/21 8:04 AM

#376349 RE: tryn2 #376343

Agreed. They have now issued 2 PRs since being unblinded (March and May) and both are focused on commercialization....hmmm

icon url

BioInvestor4

05/12/21 8:08 AM

#376354 RE: tryn2 #376343

100% agree!
icon url

MI Dendream

05/12/21 8:16 AM

#376358 RE: tryn2 #376343

Whoot whoot! Love me some great speculation and cheerleading
icon url

anders2211

05/12/21 8:18 AM

#376359 RE: tryn2 #376343

exactly

shorts, like ex, saying that they are building Sawston as a GMP for personal benefit after the trial has failed are talking out of there where the sun no shines. If the study has failed then NWBO is BK. If NWBO is BK then Sawston will be sold to satisfy NWBO's debitors.

Also the SIZE of the Sawston facility indicated an incredibly successful trial. If the trial were a minor success then one can not expect the units of products that need to be manufactured. If the trial were a minor success then future patients will not flock as big to get a unit produced as the facility now suggests.


icon url

antihama

05/12/21 3:52 PM

#376546 RE: tryn2 #376343

Yes, that's a big takeaway. My smallest takeaway was the timing of the PR release at ~4:15 EST. Usually we see a PR released at around market open and sometimes afterwards so I was a little shocked to see the PR when I checked around 7 am. I had to do a double take. It almost seems like NWBO management was in the UK and released it from there. It was released at 4:15 AM EST which corresponds to 9:15 AM London time or 10:15 in the EU (I believe). In sum, interesting in my book because it's a little different than how NWBO has released PRs in the past. Or maybe LG has insomnia?